Abstract
Fast and effective diagnosis is the first step in monitoring the current coronavirus 2 (CoV-2) pandemic. Herein, we establish a simple and sensitive electrochemical assay using magnetic nanocomposite and DNA sandwich probes to rapidly quantify the CoV-2 nucleocapsid (N) gene down to the 0.37 fM level. This assay uses a pair of specific DNA probes. The capture probe is covalently conjugated to Au-decorated magnetic reduced graphene oxide (AMrGO) nanocomposite for efficiently capturing target RNA. In contrast, the detection probe is linked to peroxidase for signal amplification. The probes target the COV-2 gene, allowing for specific magnetic separation, enzymatic signal amplification, and subsequent generation of voltammetric current with a total assay time of 45 min. The developed biosensor has high selectivity and can discriminate non-specific gene sequences. Synthetic COV-2 N-gene can be detected efficiently in serum and saliva, while 1-bp mismatch gene yielded a low response. The performance of the genosensor was good in an extensive linear range of 5 aM–50 pM. For synthetic N-gene, we achieved the detection limit of 0.37, 0.33, and 0.19 fM in human saliva, urine, and serum. This simple, selective, and sensitive genosensor could have various genetics-based biosensing and diagnostic applications.
| Original language | English |
|---|---|
| Article number | 124701 |
| Pages (from-to) | 124701 |
| Journal | Talanta |
| Volume | 262 |
| DOIs | |
| State | Published - 01 09 2023 |
Bibliographical note
Copyright © 2023 Elsevier B.V. All rights reserved.Keywords
- CoV-2
- Electrochemical biosensor
- Genosensor
- Nucleocapsid gene
- Reduced graphene oxide
- SARS-CoV-2/genetics
- Electrochemical Techniques
- Humans
- Nucleocapsid
- Graphite/chemistry
- Gold/chemistry
- COVID-19
- Biosensing Techniques
- Nanocomposites/chemistry